Your Messages Inbox
Your Article Summary
See Latest ArticlesPharmacoeconomic Analysis of Reported Use of ENTEREG (alvimopan) Published in American Journal of Health-System Pharmacy
Adolor Corporation, 09/01/09
Adolor Corporation and GlaxoSmithKline announced that an economic analysis of Phase 3 clinical trial data reported that the use of ENTEREG after bowel resection surgery decreased the amount of time patients spent in the hospital by one day, resulting in lower estimated hospital costs compared with placebo. The results, published in the American Journal of Health–System Pharmacy, were based on a post–hoc pharmacoeconomic analysis of pooled data consisting of 1,409 patients who participated in four randomized, double–blind, placebo–controlled, Phase 3 efficacy studies of ENTEREG conducted in North America.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
JAMA, 11/25/09
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Article Search
Sponsor